These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3491148)

  • 21. Regulation of human B cell proliferation by prostaglandin E2.
    Thompson PA; Jelinek DF; Lipsky PE
    J Immunol; 1984 Nov; 133(5):2446-53. PubMed ID: 6332851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 8-Mercaptoguanosine overcomes unresponsiveness of human neonatal B cells to polysaccharide antigens.
    Rijkers GT; Dollekamp I; Zegers BJ
    J Immunol; 1988 Oct; 141(7):2313-6. PubMed ID: 3262655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lyb-5- B cells of CBA/N mice can be induced to synthesize DNA by culture with insolubilized but not soluble anti-Ig.
    Mond JJ; Schaefer M; Smith J; Finkelman FD
    J Immunol; 1983 Nov; 131(5):2107-9. PubMed ID: 6195249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of lipopolysaccharide-induced polyclonal B cell activation of murine spleen with heat-aggregated murine immunoglobulin G.
    Saito-Taki T; Nakano M
    J Immunol; 1983 May; 130(5):2022-6. PubMed ID: 6220074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of rat B lymphocytes. I. Characterization of anti-immunoglobulin responses and isotype density of rat B cells.
    Rosenberg JS; Feldman JD
    J Immunol; 1982 Feb; 128(2):651-5. PubMed ID: 6798118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of cell morphology in B lymphocytes by IL-4: evidence for induced cytoskeletal changes.
    Davey EJ; Thyberg J; Conrad DH; Severinson E
    J Immunol; 1998 Jun; 160(11):5366-73. PubMed ID: 9605136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble and immobilized anti-Ig antibodies in the regulation of LPS-induced lymphoblasts.
    Symons DB; Clarkson CA; Hall FJ
    Immunology; 1985 Jan; 54(1):71-8. PubMed ID: 3871729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human B cell responsiveness by prostaglandin E2.
    Simkin NJ; Jelinek DF; Lipsky PE
    J Immunol; 1987 Feb; 138(4):1074-81. PubMed ID: 3027169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines.
    Scott DW; O'Garra A; Warren D; Klaus GG
    J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoration of in vitro responsiveness of xid B cells to TNP-Ficoll by 8-mercaptoguanosine.
    Ahmad A; Mond JJ
    J Immunol; 1986 Feb; 136(4):1223-6. PubMed ID: 3511143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation and proliferation signals in mouse B cells. II. Evidence for activation (G0 to G1) signals differing in sensitivity to cyclosporine.
    Klaus GG; Hawrylowicz CM
    Eur J Immunol; 1984 Mar; 14(3):250-4. PubMed ID: 6608449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of interleukin 1 activity from macrophages by direct interaction with C8-substituted guanine ribonucleosides.
    Goodman MG
    Int J Immunopharmacol; 1988; 10(5):579-86. PubMed ID: 3263339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant interferon-gamma inhibits the B cell proliferative response stimulated by soluble but not by Sepharose-bound anti-immunoglobulin antibody.
    Mond JJ; Finkelman FD; Sarma C; Ohara J; Serrate S
    J Immunol; 1985 Oct; 135(4):2513-7. PubMed ID: 3928753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis for the inhibition of LPS induced differentiation by anti-immunoglobulin.
    Yuan D
    J Mol Cell Immunol; 1987; 3(3):133-44. PubMed ID: 3509922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyclonal activation of the murine immune system by an antibody to IgD. IV. In vivo activation of B lymphocytes from immune defective CBA/N mice.
    Muul LM; Scher I; Mond JJ; Finkelman FD
    J Immunol; 1983 Nov; 131(5):2226-31. PubMed ID: 6605378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. II. Role of monocytes and the increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin E.
    Hasler F; Bluestein HG; Zvaifler NJ; Epstein LB
    J Immunol; 1983 Aug; 131(2):768-72. PubMed ID: 6306107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cells from M167 mu kappa transgenic mice fail to proliferate after stimulation with soluble anti-Ig antibodies. A model for antigen-induced B cell anergy.
    Sieckmann DG; Holmes K; Hornbeck P; Martin E; Guelde G; Bondada S; Longo DL; Kenny JJ
    J Immunol; 1994 May; 152(10):4873-83. PubMed ID: 8176209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.
    Ting CC; Hargrove ME
    J Immunol; 1983 Oct; 131(4):1734-41. PubMed ID: 6604751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoregulation in the rat: requirements for in vitro B cell responses to classical TI-1 and TI-2 antigens.
    Morisaki I; Eldridge JH; Michalek SM; Hamada S; McGhee JR
    J Immunol; 1983 Sep; 131(3):1131-7. PubMed ID: 6411810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of c-fos inhibits down-regulation of a cyclin-dependent kinase-2 inhibitor p27Kip1 in splenic B cells activated by surface Ig cross-linking.
    Kobayashi K; Phuchareon J; Inada K; Tomita Y; Koizumi T; Hatano M; Miyatake S; Tokuhisa T
    J Immunol; 1997 Mar; 158(5):2050-6. PubMed ID: 9036948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.